化合物 Lornoxicam-d4 T71212
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
5 mg | 1216527-48-8 | ¥3,130.00 | 询底价 |
1 mg | 1216527-48-8 | ¥857.00 | 询底价 |
10 mg | 1216527-48-8 | ¥5,820.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Lornoxicam-d4
描述: Lornoxicam-d4 is intended for use as an internal standard for the quantification of lornoxicam by GC- or LC-MS. Lornoxicam is a COX inhibitor and non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory and analgesic properties. It inhibits production of thromboxane B2 from arachidonic acid in HEL human erythroleukemic cells, which endogenously express COX-1, as well as inhibits LPS-induced formation of prostaglandin F1α from arachidonic acid in Mono-Mac-6 cells, which endogenously express COX-2. Lornoxicam reduces LPS-induced production of nitric oxide and IL-6 in cell-based assays with IC50 values of 65 and 54 µM, respectively. It reduces carrageenan-induced paw edema in rats when administered intravenously at doses ranging from 0.1 to 9 mg/kg. Formulations containing lornoxicam have been used in the management of postoperative pain.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
关键字: MT7716 | MT 7716 | Lornoxicam-d4 | MT-7716 HCl hydrate | MT-7716 hydrochloride monohydrate
化合物 Lornoxicam-d4 T71212信息由TargetMol中国为您提供,如您想了解更多关于化合物 Lornoxicam-d4 T71212报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途